Factors Affecting Levothyroxine Dose in Primary Hypothyroidism
الكلمات المفتاحية:
Levothyroxine, Hypothyroidism, Age, Sex. Body weightالملخص
Primary hypothyroidism is a deficiency of thyroid hormone due to diseases affecting the thyroid gland itself. Our objective was to determine whether age, gender, ideal body weight, and menstrual status affect levothyroxine dose in primary hypothyroidism to achieve euthyroidism. The study was performed retrospectively by reviewing the charts of patients being treated for primary hypothyroidism in the endocrinology clinic in Benghazi Diabetes Center, who had TSH values within a normal range. The selected patients were taking LT4 without any confounding medications and had no serious chronic conditions. All the subjects of primary hypothyroidism on maintenance dose for at least 12 months were considered. The total number of subjects with primary hypothyroidism was 539; only 100 subjects were eligible for the study. Subjects included both men & women between the ages of 24 & 88 years who have primary hypothyroidism. TSH parameters across study groups ANOVA test (P=0.058, no significant difference). Weight-based LT4 dose parameters across study groups. The difference is not statistically significant between men, premenopausal women, and menopausal women. Dot plot for the relationship between age, weight, and mean LT4 weight-based dose (statistically not significant relationship). Dot plot for the relationship between mean TSH level and mean LT4 weight-based dose (statistically not significant relationship). The LT4 dose is not primarily driven by a patient’s Age, gender, or menstrual status, but it is by body weight. This knowledge may eventually improve the ability to predict a patient’s dose requirement and thus more quickly attain a euthyroid status when initiating LT4 therapy.
المراجع
1. Ralston SH, Penman ID, SMW J, Hobson RP. Davidson’s Principles and Practice of Medicine. London: Elsevier; 2018. pp. 634-642
2. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber for the American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012 Dec;22(12):1200-35.
3. Roti E, Minelli R, Gardini E, Braverman LE. The use and misuse of thyroid hormone. Endocrine reviews. 1993 Aug 1;14(4):401-23.
4. Cerqueira C, Knudsen N, Ovesen L, Laurberg P, Perrild H, Rasmussen LB, Jørgensen T. Doubling in the use of thyroid hormone replacement therapy in Denmark: association to iodization of salt? European journal of epidemiology. 2011 Aug;26(8):629-35.
5. Mitchell AL, Hickey B, Hickey JL, Pearce SH. Trends in thyroid hormone prescribing and consumption in the UK. BMC public health. 2009 May 11;9(1):132.
6. Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Medical Clinics. 2012 Mar 1;96(2):203-21.
7. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber for the American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012 Dec;22(12):1200-35.
8. Devdhar M, Drooger R, Pehlivanova M, Singh G, Jonklaas J. Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid. 2011 Aug;21(8):821-7.
9. Tan NC, Chew RQ, Koh YL, Subramanian RC, Sankari U, Meyappan M, Cho LW. Primary hypothyroidism in the community: lower daily dosages of levothyroxine replacement therapy for Asian patients. Medicine. 2017 Feb 1;96(7): e6145.
10. Jonklaas J. Sex and age differences in levothyroxine dosage requirement. Endocrine Practice. 2010 Jan 1;16(1):71-9.
11. Centanni M, Santaguida MG, Gargano L. Malabsorption of T4: new insights on oral thyroxine treatment. Hot Thyroidology. 2007; 169:1-4.
12. Benvenga S, Bartolone L, Squadrito S, Giudice FL, Trimarchi F. Delayed intestinal absorption of levothyroxine. Thyroid. 1995 Aug;5(4):249-53.